1.85 USD
-0.15 (-7.5%)
1.86 USD
+0.01 (+0.54%)
ChartMill assigns a Buy % Consensus number of 80% to NBY. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 0.87. This target is -53.14% below the current price.
- NBY was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NBY.
- In the previous month the buy percentage consensus was at a similar level.
- Only 5 analysts analyzed NBY. So this is just the average opinion of a couple of analysts.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-11 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-08-11 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2022-05-20 | Ascendiant Capital | Maintains | Buy |
NOVABAY PHARMACEUTICALS INC / NBY FAQ
Can you provide the average price target for NOVABAY PHARMACEUTICALS INC stock?
5 analysts have analysed NBY and the average price target is 0.87 USD. This implies a price decrease of -53.14% is expected in the next year compared to the current price of 1.85.
How do analysts rate NOVABAY PHARMACEUTICALS INC (NBY)?
The consensus rating for NOVABAY PHARMACEUTICALS INC (NBY) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover NOVABAY PHARMACEUTICALS INC (NBY) stock?
The number of analysts covering NOVABAY PHARMACEUTICALS INC (NBY) is 5.